142 related articles for article (PubMed ID: 37796435)
1. Cytotoxic pathways activated by multifunctional thiosemicarbazones targeting sigma-2 receptors in breast and lung carcinoma cells.
Kopecka J; Barbanente A; Vitone D; Arnesano F; Margiotta N; Berchialla P; Niso M; Riganti C; Abate C
Pharmacol Rep; 2023 Dec; 75(6):1588-1596. PubMed ID: 37796435
[TBL] [Abstract][Full Text] [Related]
2. Multifunctional thiosemicarbazones targeting sigma receptors: in vitro and in vivo antitumor activities in pancreatic cancer models.
Niso M; Kopecka J; Abatematteo FS; Berardi F; Riganti C; Abate C
Cell Oncol (Dordr); 2021 Dec; 44(6):1307-1323. PubMed ID: 34586588
[TBL] [Abstract][Full Text] [Related]
3. Multifunctional thiosemicarbazones and deconstructed analogues as a strategy to study the involvement of metal chelation, Sigma-2 (σ
Pati ML; Niso M; Spitzer D; Berardi F; Contino M; Riganti C; Hawkins WG; Abate C
Eur J Med Chem; 2018 Jan; 144():359-371. PubMed ID: 29287249
[TBL] [Abstract][Full Text] [Related]
4. N
Sólimo A; Soraires Santacruz MC; Loaiza Perez AI; Bal de Kier Joffé E; Finkielsztein LM; Callero MA
J Cell Physiol; 2018 Jun; 233(6):4677-4687. PubMed ID: 29111571
[TBL] [Abstract][Full Text] [Related]
5. Novel thiosemicarbazones induce high toxicity in estrogen-receptor-positive breast cancer cells (MCF7) and exacerbate cisplatin effectiveness in triple-negative breast (MDA-MB231) and lung adenocarcinoma (A549) cells.
Medina-Reyes EI; Mancera-Rodríguez MA; Delgado-Buenrostro NL; Moreno-Rodríguez A; Bautista-Martínez JL; Díaz-Velásquez CE; Martínez-Alarcón SA; Torrens H; de Los Ángeles Godínez-Rodríguez M; Terrazas-Valdés LI; Chirino YI; Vaca-Paniagua F
Invest New Drugs; 2020 Jun; 38(3):558-573. PubMed ID: 31177399
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, cytotoxicity, and antitumor activity of copper(II) and iron(II) complexes of (4)N-azabicyclo[3.2.2]nonane thiosemicarbazones derived from acyl diazines.
Easmon J; Pürstinger G; Heinisch G; Roth T; Fiebig HH; Holzer W; Jäger W; Jenny M; Hofmann J
J Med Chem; 2001 Jun; 44(13):2164-71. PubMed ID: 11405653
[TBL] [Abstract][Full Text] [Related]
7. Selective sigma-2 ligands preferentially bind to pancreatic adenocarcinomas: applications in diagnostic imaging and therapy.
Kashiwagi H; McDunn JE; Simon PO; Goedegebuure PS; Xu J; Jones L; Chang K; Johnston F; Trinkaus K; Hotchkiss RS; Mach RH; Hawkins WG
Mol Cancer; 2007 Jul; 6():48. PubMed ID: 17631687
[TBL] [Abstract][Full Text] [Related]
8. Sigma-2 receptor ligand as a novel method for delivering a SMAC mimetic drug for treating ovarian cancer.
Zeng C; Vangveravong S; McDunn JE; Hawkins WG; Mach RH
Br J Cancer; 2013 Oct; 109(9):2368-77. PubMed ID: 24104966
[TBL] [Abstract][Full Text] [Related]
9. New Pharmacological Strategies against Pancreatic Adenocarcinoma: The Multifunctional Thiosemicarbazone FA4.
Anobile DP; Niso M; Puerta A; Fraga Rodrigues SM; Abatematteo FS; Avan A; Abate C; Riganti C; Giovannetti E
Molecules; 2022 Mar; 27(5):. PubMed ID: 35268783
[TBL] [Abstract][Full Text] [Related]
10. Anti-tumor effects and mechanism of GA-13315, a novel gibberellin derivative, in human lung adenocarcinoma: an in vitro and in vivo study.
Xie L; Chen Y; Chen J; Zhang H; Liao Y; Zhou Y; Zhou L; Qing C
Cell Mol Biol Lett; 2019; 24():6. PubMed ID: 30651744
[TBL] [Abstract][Full Text] [Related]
11. Sigma-2 receptor agonist derivatives of 1-Cyclohexyl-4-[3-(5-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)propyl]piperazine (PB28) induce cell death via mitochondrial superoxide production and caspase activation in pancreatic cancer.
Pati ML; Hornick JR; Niso M; Berardi F; Spitzer D; Abate C; Hawkins W
BMC Cancer; 2017 Jan; 17(1):51. PubMed ID: 28086830
[TBL] [Abstract][Full Text] [Related]
12. Lysosomal membrane permeabilization is an early event in Sigma-2 receptor ligand mediated cell death in pancreatic cancer.
Hornick JR; Vangveravong S; Spitzer D; Abate C; Berardi F; Goedegebuure P; Mach RH; Hawkins WG
J Exp Clin Cancer Res; 2012 May; 31(1):41. PubMed ID: 22551149
[TBL] [Abstract][Full Text] [Related]
13. Small molecule antagonists of the sigma-1 receptor cause selective release of the death program in tumor and self-reliant cells and inhibit tumor growth in vitro and in vivo.
Spruce BA; Campbell LA; McTavish N; Cooper MA; Appleyard MV; O'Neill M; Howie J; Samson J; Watt S; Murray K; McLean D; Leslie NR; Safrany ST; Ferguson MJ; Peters JA; Prescott AR; Box G; Hayes A; Nutley B; Raynaud F; Downes CP; Lambert JJ; Thompson AM; Eccles S
Cancer Res; 2004 Jul; 64(14):4875-86. PubMed ID: 15256458
[TBL] [Abstract][Full Text] [Related]
14. The sigma-2 receptor as a therapeutic target for drug delivery in triple negative breast cancer.
Makvandi M; Tilahun ED; Lieberman BP; Anderson RC; Zeng C; Xu K; Hou C; McDonald ES; Pryma DA; Mach RH
Biochem Biophys Res Commun; 2015 Nov; 467(4):1070-5. PubMed ID: 26453012
[TBL] [Abstract][Full Text] [Related]
15. Sigma-2 receptor agonists activate a novel apoptotic pathway and potentiate antineoplastic drugs in breast tumor cell lines.
Crawford KW; Bowen WD
Cancer Res; 2002 Jan; 62(1):313-22. PubMed ID: 11782394
[TBL] [Abstract][Full Text] [Related]
16. The variable chemotherapeutic response of Malabaricone-A in leukemic and solid tumor cell lines depends on the degree of redox imbalance.
Manna A; De Sarkar S; De S; Bauri AK; Chattopadhyay S; Chatterjee M
Phytomedicine; 2015 Jul; 22(7-8):713-23. PubMed ID: 26141757
[TBL] [Abstract][Full Text] [Related]
17. Identification and characterization of MAM03055A: A novel bivalent sigma-2 receptor/TMEM97 ligand with cytotoxic activity.
Liu CZ; Mottinelli M; Nicholson HE; McVeigh BM; Wong NK; McCurdy CR; Bowen WD
Eur J Pharmacol; 2021 Sep; 906():174263. PubMed ID: 34144027
[TBL] [Abstract][Full Text] [Related]
18. Incorporation of a selective sigma-2 receptor ligand enhances uptake of liposomes by multiple cancer cells.
Zhang Y; Huang Y; Zhang P; Gao X; Gibbs RB; Li S
Int J Nanomedicine; 2012; 7():4473-85. PubMed ID: 22927761
[TBL] [Abstract][Full Text] [Related]
19. Cyclohexylpiperazine derivative PB28, a sigma2 agonist and sigma1 antagonist receptor, inhibits cell growth, modulates P-glycoprotein, and synergizes with anthracyclines in breast cancer.
Azzariti A; Colabufo NA; Berardi F; Porcelli L; Niso M; Simone GM; Perrone R; Paradiso A
Mol Cancer Ther; 2006 Jul; 5(7):1807-16. PubMed ID: 16891467
[TBL] [Abstract][Full Text] [Related]
20. Caspase-Dependent Apoptosis Induced by Simarouba Glauca on Human Non-Small-Cell Lung Cancer, A549 Cells.
Vikas B; Sujathan K; Rajam SSN; Anil S
Asian Pac J Cancer Prev; 2022 Jun; 23(6):1867-1872. PubMed ID: 35763625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
